Global Transdermal Drug Patches Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global Transdermal Drug Patches Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

A transdermal patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body.

Market Overview:

The latest research study on the global Transdermal Drug Patches market finds that the global Transdermal Drug Patches market reached a value of USD 6803.53 million in 2022. It’s expected that the market will achieve USD 9301.51 million by 2028, exhibiting a CAGR of 5.35% during the forecast period.

Improve performance

In the future, the manufacturers tend to increase research and development efforts, apply for certification in different regions, improve their productivity and create competitive advantage, such as offering high performance product at a cost-effective price point. For example, for different diseases to developing suitable Transdermal Drug Patches, especially the use of drugs, because of the special nature of Transdermal Drug Patches, only small molecules can penetrate into the skin, so the development of different drugs is the key.

Emerging countries

For example, China, India, Southeast Asia, South America, have a large population in the world, with the progress of the economy, and development of local enterprises, the market of Transdermal Drug Patches has great market potential in those Regions.

Focus on product compliance

Transdermal Drug Patches, as a new type of medical product, require the approval of the drug regulatory authority in different regions to enter the market. Therefore, in the future, suppliers will increase their research and development efforts on new products, pay attention to product compliance, and strive to obtain marketing licenses in more regions, which will be one of the opportunities for the market to seek growth.

Region Overview:

In global comparison, a significant portion of the revenue was generated in North America (35.73% in 2022).

Company Overview:

Hisamitsu Pharmaceutical Co., Inc. is one of the major players operating in the Transdermal Drug Patches market, holding a share of 10.29% in 2023.

Hisamitsu Pharmaceutical Co., Inc.

Hisamitsu Pharmaceutical Co., Inc. engages in the research and development, manufacture, purchase, and sale of pharmaceuticals.

Mylan N.V.

Mylan N.V., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic, branded-generic, brand-name, and over-the-counter (OTC) pharmaceutical products in North America, Europe, and internationally.

Segmentation Overview:

Among different product types, Fentanyl Transdermal Patch segment is anticipated to contribute the largest market share in 2028.

Fentanyl Transdermal Patch

Fentanyl (also known as fentanyl) is an opioid that can be used as an analgesic and other anesthetic. Fentanyl Transdermal Patch is used to manage persistent, moderate to severe chronic pain in patients with opioid tolerance. There are several dose strengths to choose from; patches need to be changed every three days.

Nicotine Transdermal Patch

A nicotine transdermal patch is a transdermal patch that releases nicotine into the body through the skin. It is used in nicotine replacement therapy (NRT), a process for smoking cessation. One can gradually reduce the dose of nicotine obtained from the patch. The goal is to stop using nicotine altogether. Some people who are trying to quit have found that a stable amount of nicotine is better than a patch of nicotine using chewing gum or lozenges. Nicotine patches can be used without a prescription.

Buprenorphine Transdermal Patch

Buprenorphine is a partial agonist of opioids. Buprenorphine Transdermal Patch is used to relieve pain in patients who are expected to have painkillers for long periods of time and who cannot be treated with other medications. It works by changing the way the brain and nervous system respond to pain.

Clonidine Transdermal Patch

Clonidine Transdermal Patch is used alone or in combination with other drugs to treat high blood pressure. It is a drug called a centrally acting alpha-agonist antihypertensive drug. It allows blood to flow better through the blood vessels by lowering the heart rate and relaxing the blood vessels.

Oxybutynin Transdermal Patch

Oxybutynin Transdermal Patch is used to treat overactive bladder (uncontrolled bladder muscles cause contractions that cause frequent urination, continued urination or uncontrollable urination). Oxybutynin Transdermal Patch belongs to a class of drugs called antimuscarinic drugs.

Application Overview:

By application, the Analgesia segment occupied the biggest share from 2018 to 2022.

Key Companies in the global Transdermal Drug Patches market covered in Chapter 3:

Nitto Denko Corporation
NAL Pharmaceutical Group Limited
Boehringer Ingelheim
LTS Lohmann Therapie-Systeme AG
Mylan N.V.
Novartis International AG
Hisamitsu Pharmaceutical Co., Inc.
GlaxoSmithKline
Johnson & Johnson
Endo International
Teikoku Seiyaku
UCB

In Chapter 4 and Chapter 14.2, on the basis of types, the Transdermal Drug Patches market from 2018 to 2029 is primarily split into:

Fentanyl Transdermal Patch
Nicotine Transdermal Patch
Buprenorphine Transdermal Patch
Clonidine Transdermal Patch
Oxybutynin Transdermal Patch
Others

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Transdermal Drug Patches market from 2018 to 2029 covers:

Hypertension
Contraception
Analgesia
Smoking Cessation
Angina
Hormone Replacement
Others

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)